Filing Details
- Accession Number:
- 0001209191-19-043052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-24 16:51:16
- Reporting Period:
- 2019-07-22
- Accepted Time:
- 2019-07-24 16:51:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1694560 | New Enterprise Associates 16, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
| 1712881 | Nea Partners 16, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
| 1712882 | Nea 16 Gp, Llc | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-22 | 3,736,243 | $0.00 | 3,736,243 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-07-22 | 450,000 | $15.00 | 4,186,243 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2019-07-22 | 29,889,945 | $0.00 | 3,736,243 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct |
Footnotes
- Automatic conversion, in connection with the Issuer's initial public offering, of each share of the Issuer's Series A preferred stock into 0.125shares of the Issuer's common stock. The shares have no expiration date.
- The shares are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managersof NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").Theindividual managers of NEA 16 GP are Peter J. Barris, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., MohamadMakhzoumi, Josh Makower, David M. Mott, Scott D. Sandell, Peter W. Sonsini and Paul Walker. The Indirect Reporting Persons disclaimbeneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of theshares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
